Patents by Inventor Janine M. Morales

Janine M. Morales has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nucleic acids encoding CCL27
    Patent number: 8119786
    Abstract: Novel CC chemokines from human, reagents related thereto including purified proteins, specific antibodies and nucleic acids encoding these chemokines are provided. Also provided are methods of making and using said reagents and diagnostic kits.
    Type: Grant
    Filed: September 14, 2009
    Date of Patent: February 21, 2012
    Assignee: Schering Corporation
    Inventors: Alain Vicari, Janine M. Morales, Joseph Hedrick, Albert Zlotnik
  • MAMMALIAN CHEMOKINES; RELATED REAGENTS
    Publication number: 20100093630
    Abstract: Novel CC chemokines from human, reagents related thereto including purified proteins, specific antibodies and nucleic acids encoding these chemokines are provided. Also provided are methods of making and using said reagents and diagnostic kits.
    Type: Application
    Filed: September 14, 2009
    Publication date: April 15, 2010
    Inventors: Alain P. Vicari, Janine M. Morales, Joseph Hedrick, Albert Zlotnik
  • Anti-CCL27 antibodies
    Patent number: 7601815
    Abstract: Novel CC chemokines from human, reagents related thereto including purified proteins, specific antibodies and nucleic acids encoding these chemokines are provided. Also provided are methods of making and using said reagents and diagnostic kits.
    Type: Grant
    Filed: May 16, 2006
    Date of Patent: October 13, 2009
    Assignee: Schering Corporation
    Inventors: Alain P. Vicari, Janine M. Morales, Joseph A. Hedrick, Albert Zlotnik
  • CCL27 polypeptides
    Patent number: 7101987
    Abstract: Novel CC chemokines from human, reagents related thereto including purified proteins, specific antibodies and nucleic acids encoding these chemokines are provided. Also provided are methods of making and using said reagents and diagnostic kits.
    Type: Grant
    Filed: May 15, 2002
    Date of Patent: September 5, 2006
    Assignee: Schering Corporation
    Inventors: Alain P. Vicari, Janine M. Morales, Joseph A. Hedrick, Albert Zlotnik
  • Method of impairing movement of a CLA + memeory T-cell within or to the skin of a mammal by administering a CTACK antagonist
    Patent number: 6824781
    Abstract: Agonists or antagonists of CTACK or Vic chemokines, and various methods of use in dermatological and related applications are provided. In particular, the method makes use of fact that the CTACK or Vic chemokines are specifically capable of inducing movement of a skin cell subset. Moreover, matching of ligand with GPR2 receptor in mammals provides methods of use.
    Type: Grant
    Filed: July 2, 2001
    Date of Patent: November 30, 2004
    Assignee: Schering Corporation
    Inventors: Wei Wang, Elizabeth R. Oldham, Hortensia Soto, Ying Liu, Susan A. Hudak, Bernhard Homey, Janine M. Morales, Sirid-Aimee Kellermann, Leslie M. McEvoy, Edward P. Bowman, Albert Zlotnik
  • Mammalian chemokines; related reagents
    Publication number: 20030031646
    Abstract: Novel CC chemokines from human, reagents related thereto including purified proteins, specific antibodies and nucleic acids encoding these chemokines are provided. Also provided are methods of making and using said reagents and diagnostic kits.
    Type: Application
    Filed: May 15, 2002
    Publication date: February 13, 2003
    Inventors: Alain P. Vicari, Janine M. Morales, Joseph A. Hedrick, Albert Zlotnik
  • Chemokine and receptor uses; compositions; methods
    Publication number: 20020160024
    Abstract: Agonists or antagonists of CTACK or Vic chemokines, and various methods of use in dermatological and related applications are provided. In particular, the method makes use of fact that the CTACK or Vic chemokines are specifically capable of inducing movement of a skin cell subset. Moreover, matching of ligand with GPR2 receptor in mammals provides methods of use.
    Type: Application
    Filed: July 2, 2001
    Publication date: October 31, 2002
    Applicant: Schering Corpration, a New Jersey corporation
    Inventors: Wei Wang, Elizabeth R. Oldham, Hortensia Soto, Ying Liu, Susan A. Hudak, Bernhard Homey, Janine M. Morales, Sirid-Aimee Kellermann, Leslie M. McEvoy, Edward P. Bowman, Albert Zlotnik